Ibogaine is a non-classical psychedelic that breaks the cycle of addiction to opioids, cocaine and other abused drugs. In the 1960’s, American and European self-help groups provided public testimonials that a single dose of ibogaine alleviated drug craving, opioid withdrawal symptoms, and prevented relapse for weeks, months and sometimes years. The claimed therapeutic benefits of ibogaine which treat the underlying disease instead of targeting symptoms to prevent relapse support the current resurgence of ibogaine’s clinical development for inpatient use.